Industry News
Genetic Code Cracked For A Devastating Blood Parasite
Jan 20, 2012
Scientists have cracked the genetic code and predicted some high priority drug targets for the blood parasite Schistosoma haematobium, which is linked to bladder cancer and HIV/ AIDS and causes the insidious urogenital disease schistosomiasis haematobia in more than 112 million people in Africa... Read More
Tumors Continue Growing Even When Cells Get Old
Jan 19, 2012
Based on the knowledge that cancer cells grow indefinitely, the general belief is that senescence could act as a barrier against tumor growth and has the potential of being used as a cancer treatment... Read More
Tumors Continue Growing Even When Cells Get Old
Jan 19, 2012
Based on the knowledge that cancer cells grow indefinitely, the general belief is that senescence could act as a barrier against tumor growth and has the potential of being used as a cancer treatment... Read More
Oesophageal Cancer Gene Found
Jan 19, 2012
UK researchers have found a gene that plays an important part in the development of oesophageal cancer or cancer of the gullet. They announced their news to the press on Thursday. Every year, more than 8,000 people in the UK discover they have oesophageal cancer, and the rates are going up. The disease is more common in the UK than other European countries... Read More
Tykerb And Herceptin - Their Role In Breast Cancer Treatment Clarified
Jan 19, 2012
Patients with HER2-positive breast cancer have been treated with Tykerb (lapatinib) both in combination with herceptin (trastuzumab), and as an alternative single-agent therapy for pre-surgery (neo-adjuvant) chemotherapy... Read More
TB And A Gene Mutation That Causes Lung Cancer Linked
Jan 19, 2012
Tuberculosis (TB) has been suspected to increase a person's risk of lung cancer because the pulmonary inflammation and fibrosis can induce genetic damage. However, direct evidence of specific genetic changes and the disease have not been extensively reported... Read More
Successful Trial Shows Drug Improves Survival Of Colorectal Cancer Patients
Jan 19, 2012
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D... Read More
New Advances Aimed At Improving Treatment, Prognosis And Detection Of GI Cancers: 2012 Gastroinstestinal Cancers Symposium
Jan 19, 2012
New research into the treatment, prognosis and early detection of gastrointestinal cancers was released in advance of the ninth annual Gastrointestinal Cancers Symposium being held January 19-21, 2012, at The Moscone West Building in San Francisco, Calif... Read More
Key To Stopping Growth And Migration Of Brain Cancer Cells Is Cell Signaling
Jan 19, 2012
Brain cancer is hard to treat: it's not only strong enough to resist most chemotherapies, but also nimble enough to migrate away from radiation or surgery to regrow elsewhere. New research at the University of Colorado Cancer Center shows how to stop both. Specifically, cells signal themselves to survive, grow, reproduce, and migrate... Read More
Cost To The Nation For Job-Related Injuries And Illnesses Estimated At $250 Billion Per Year
Jan 19, 2012
In the first comprehensive review of its kind since 1992, a UC Davis researcher has estimated the national annual price tag of occupational injuries and illnesses at $250 billion, much higher than generally assumed. That figure is $31 billion more than the direct and indirect costs of all cancer, $76 billion more than diabetes and $187 billion more than strokes... Read More
Previous Page Next Page